Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
September 15, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual...
Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
September 10, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Opportunities in the Contract Manufacturing Market in China - China's mAb Therapeutics is Forecast to Grow to $26 Billion by 2030
September 08, 2020 07:33 ET
|
Research and Markets
Dublin, Sept. 08, 2020 (GLOBE NEWSWIRE) -- The "Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities" report has been added to...
Global CDMO Industry Insights Report 2019-2025: Market Size Breakdown by Type of Service, Type of Molecule, End Use and Region
September 02, 2020 05:19 ET
|
Research and Markets
Dublin, Sept. 02, 2020 (GLOBE NEWSWIRE) -- The "Global Market Opportunities and Competitive Landscape for CDMO" report has been added to ResearchAndMarkets.com's offering. This report provides an...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2020 and Recent Developments
September 01, 2020 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $25.4 Million -- -- Signed Three New Customers and Project Expansion Orders with Current Customers for $20 Million -- -- Backlog of $60 Million at Quarter-End --...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
August 31, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Contract Manufacturing Organization Market to Reach USD 188.07 Billion by 2026; High Prevalence of Numerous Types of Cancer Will Provide Impetus to market Growth, says Fortune Business Insights™
August 28, 2020 03:56 ET
|
Fortune Business Insights
Pune, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The global contract manufacturing organization market size is projected to reach USD 188.07 billion by the end of 2026, the market was worth USD 92.42 billion...
Medical Device Contract Manufacturing Market to reach US $133.11 billion by 2028 - Global Insights on Trends, Size, Growth Drivers, COVID-19 Impact Analysis, Top Players, Opportunities and Future Outlook: Adroit Market Research
August 27, 2020 07:40 ET
|
Adroit Market Research
Dallas, Texas, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The “Global Medical Device Contract Manufacturing Market, by Product (IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery...
Avid Bioservices Selected by Mapp Biopharmaceutical, Inc. for Clinical Development of Novel Human Monoclonal Antiviral Antibody
August 26, 2020 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2021 After Market Close on September 1, 2020
August 25, 2020 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...